Background. -As the number of transcatheter aortic valve implantation (TAVI) procedures is constantly increasing, it is important to consider common complications, such as pacemaker (PM) implantation, and their specific risk factors. Aims. -Echocardiographic, computed tomography and electrocardiographic data were analysed to determine the predicting factors, if any, associated with PM implantation. Methods. -This retrospective study included patients referred to Nancy University Hospital for a TAVI procedure from January 2013 to December 2015. Both Medtronic CoreValve and Edwards SAPIEN valves were implanted. Patients with preprocedurally implanted PMs and/or referred from another institution were excluded. Results. -Of 208 TAVI patients, 23 had a pre-existing PM and were excluded. A new PM was required in 38 patients (20.5%). Pre-existing right bundle branch block (RBBB), the use of the Medtronic CoreValve and large prostheses were identified as predictors of PM implantation (P = 0.0361, P = 0.0004 and P = 0.0019, respectively). Using logistic regression, predictors of PM implantation included first-degree atrioventricular block (odds ratio 3.7, 95% confidence interval 1.5-9.1; P = 0.0054) and large aortic annulus diameter in echocardiography (odds ratio 1.2, 95% confidence interval 1-1.4; P = 0.0447), with a threshold of 24.1 mm. For the combination of preTAVI PR duration > 220 ms and QRS duration > 120 ms, the positive predictive value for PM implantation reached 80%.
Incidence, indications and predicting factors of permanent pacemaker implantation after transcatheter aortic valve implantation: A retrospective study

Analyse rétrospective de l'incidence, des indications et des facteurs prédictifs d'implantation de stimulateurs cardiaques définitifs après remplacement valvulaire aortique percutané
Background
The prevalence of calcific aortic valve disease approaches 25% in adults aged > 65 years [1] . Severe symptomatic aortic stenosis is associated with a poor outcome unless an aortic valve replacement procedure is performed [2] . The standard treatment for severe aortic valvular stenosis is surgical valve replacement. However, transcatheter aortic valve implantation (TAVI) is an alternative for candidates who are inoperable or at very high surgical risk [3] [4] [5] . The incidence of permanent pacemaker (PM) implantation after isolated surgical aortic valve replacement for aortic stenosis ranges from 3.2% to 7.1% [6] . The use of aortic valve replacement has been shown to reduce mortality among high-risk patients with aortic stenosis who are not candidates for surgical replacement [5] . As the number of TAVI procedures is increasing, it is important to consider complications, such as PM implantation. TAVI can affect the conduction tissue at various levels because of the vicinity of the A-V node and the infranodal conduction system to the aortic valvular complex [7] [8] [9] .
Furthermore, patients with severe aortic stenosis commonly have baseline atrioventricular (AV) conduction disturbances [10, 11] , which can only be enhanced by the TAVI procedure. Indeed, barotrauma, haemorrhage and ischaemia are known mechanisms leading to an alteration in AV and ventricular conduction tissue during or after TAVI. PM incidence varies with the valve system used [6, 12] .
There are no specific recommendations for PM implantation after TAVI [13] . This is the result of practice heterogeneity between centres -some perform prophylactic implantation, whereas others perform long-term monitoring, which may increase the rate of infection or tamponade.
This study aimed to assess predictors of PM implantation after TAVI by analysing preTAVI electrocardiographic, computed tomography (CT), clinical and echocardiographic information in order to better handle post-TAVI rhythm disorders.
Methods
Study population
The study population consisted of all patients undergoing TAVI at Nancy University Hospital from January 2013 to December 2015. According to the recommendations, patients included had severe symptomatic aortic stenosis with a valve area <1 cm 2 or <0.6 cm 2 /m 2 , with a high EuroSCORE, and TAVI was decided on by a multidisciplinary heart team. All patients gave written informed consent, and data were recorded anonymously. Clinical data were extracted from medical records and the French registry ''FRANCE TAVI'' [14, 15] .
Electrocardiographic data
Electrocardiographic records were obtained from patients at baseline, immediately after the procedure and daily until hospital discharge. The diagnosis of intraventricular conduction abnormalities was based on the American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society recommendations for the standardization and interpretation of electrocardiograms. Electrocardiogram assessment included heart rhythm, PQ, QRS and QRS morphology. Left bundle branch block was defined as a QRS duration > 120 ms, with a broad, notched R wave in leads I, aVL, V5 and V6, and an R peak time >60 ms in V5 or V6. Right bundle branch block (RBBB) was defined as a QRS duration ≥ 120 ms, with rsr', rsR' or rSR' in leads V1 or V2 [16] [17] [18] . QRS and PR durations were measured by visual inspection and by manual adjustment of the computer-generated automatic annotation, if applicable.
Echocardiography
Standard transthoracic echocardiography was performed at baseline and at hospital discharge, using a commercially available ultrasound system (Vivid 7 or Vivid 9; General Electric, Horten, Norway). The parasternal long-and short-axis views and the three standard left-ventricular apical views (four, two and three chambers) were acquired at a frame rate of 50-70 frames/s, and the left ventricular ejection fraction was obtained by the biplane Simpson's method. The mean gradient ( P) was calculated from a traced velocity curve in continuous-wave Doppler in multiple acoustic windows. This curve also allowed the peak aortic jet velocity to be obtained. The left ventricular outflow tract diameter was obtained in the parasternal long-axis view, and was measured during systole, from the insertion of the aortic cusp at the level of ventricular septum to the insertion of the aortic cusp at the level of the anterior mitral leaflet [19] [20] [21] [22] .
Cardiac computed tomography
Patients underwent native and contrast-enhanced computed tomography (CT) before TAVI with the Lightspeed VCT scanner (General Electric Medical Systems, Waukesha, WI, USA; 2005) before January 2015 and the Revolution scanner (General Electric Medical Systems, Waukesha, WI, USA; 2014) after January 2015. Acquisition was performed during an inspiratory breath hold, and the electrocardiogram was recorded simultaneously to allow retrospective gating of the data. CT analyses were performed in accordance with protocols on standardized imaging for aortovalvular sizing [23, 24] . CT allowed planimetry of the valve area and quantitative measurement of valve calcification, aortic annulus size and the annular to coronary ostial distance [25] [26] [27] [28] .
TAVI procedure
The choice of prosthesis type was at the discretion of the surgeon. Selection of the device size depended on aortic valve complex measurements obtained by echocardiography and CT. Medtronic CoreValve prostheses (Medtronic Inc., Minneapolis, MN, USA) were available in sizes 23, 26, 29 and 31. Edwards SAPIEN prostheses (Edwards Lifesciences, Irvine, CA, USA) were available in sizes 23, 26 and 29. Positioning and deployment of the device was performed under fluoroscopic and angiographic guidance. All procedures were performed with predilatation, except for the transapical approach.
Pacemaker
PM type and indication were extracted from surgical reports. Indications were: permanent or paroxysmal complete AV block; Mobitz II AV block; sinoatrial block; slow atrial fibrillation (< 40 bpm); alternating bundle branch block; or sick sinus syndrome.
Statistical analysis
The characteristics of the sample are described as percentages for categorical variables and as means, standard deviations, medians, quartiles and minimum/maximum values for continuous variables.
Parametric statistics were used: Pearson's 2 test was used to compare categorical variables; and the analysis of variance F statistic was used for quantitative variables. Logistic regression models were used to determine the factors associated with PM implantation. Sensitivity and specificity values according to different variables were represented graphically to help to choose the optimal cut-off. The alpha risk was 5% for all analysis. Only factors with a P value < 0.2 in the bivariate model were included in the multivariable model. Statistical analyses were performed using SAS software, version 9.4 (SAS Institute, Cary, NC, USA).
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Results
Between January 2013 and December 2015, a total of 303 TAVI procedures were performed at Nancy University Hospital. In four patients, the procedure was unsuccessful because of a failed approach (n = 2) or failed deployment (n = 2), and there were eight periprocedural deaths, with a total number of 291 patients alive with a successful procedure. Full data could not be obtained from 83 of these 291 patients referred from other institutions (missing CT and/or echocardiographic data). A further 23 patients implanted with a PM before the TAVI procedure were excluded, leading to a final number of 185 included patients (Fig. 1) . The mean EuroSCORE was 20.1 ± 13.9.
After TAVI, PM implantation was required in 38 patients (20.5%, PM group). The PM and no PM groups were similar with respect to baseline clinical characteristics (Table 1) .
Procedural characteristics and complications
The access route for TAVI was transfemoral in 133 patients (71.9%), transapical in 31 (10.3%), transcarotid in 19 (10.3%) and subclavian in two (1.1%). The Edwards SAPIEN prosthesis was implanted in 123 patients (66.5%) and Incidence, indications and predicting factors of permanent pacemaker implantation after TAVI There was no difference in the age of implanted versus non-implanted patients. Indications for PMs are reported in Table 2 , paroxysmal or persistent complete AV block being the most common PM indications. Transient periprocedural paroxysmal complete AV block with complete subsequent AV conduction recovery was not considered as a PM indication. The 11 patients in whom the PM indication was defined as paroxysmal complete AV block developed this conduction disorder a mean of 6.75 days (range, 3-9 days) after the procedure. A single-chamber PM was implanted in six patients (15.8%), whereas the remaining 32 patients (84.2%) received a dual-chamber device. In the four patients in whom the PM indication was prolonged PR intervals and left bundle branch block, mean PR intervals and QRS widths increased from 168 ms and 95 ms (preprocedural values) to 285 ms and 140 ms (postprocedural values), respectively. The venous approach for leads was cephalic in 34 patients (89.5%) and subclavian for the four remaining patients (10.5%). The sole complication was one haematoma.
Statistical analysis
Electrocardiographic, echocardiographic and CT comparisons between the PM and no PM groups using the univariate analysis are described in Table 3 .
PM implantation was significantly related to preTAVI PR interval (190.6 ms vs 172.1 ms; P = 0.0084), pre-existing RBBB (13.2% vs. 4.1%; P = 0.0361) and preTAVI QRS duration (95.3 vs 86.4; P = 0.0255). Aortic annulus diameter in echocardiography was greater in the PM group (24.3 vs 23.5; P = 0.0379).
CT data revealed that the aortic valve surface was significantly larger in the PM group (5.41 vs 4.70 cm 2 ; P = 0.0026). A higher right coronary insertion was also related to a higher incidence of PM implantation (15.8 vs 14.2 mm; P = 0.0254).
Variables for the multivariable logistic regression analysis are shown in Table 4 . Independent PM predictors included first-degree AV block (OR: 3.7, 95% CI: 1.5-9.1; P = 0.0054), a large echocardiographic aortic annulus diameter, with a threshold of 24.1 mm (OR: 1.2, 95% CI: 1-1.4; P = 0.0447) and a high body mass index (OR: 1.1, 95% CI: 1.0-1.2; P = 0.0191). For PR duration > 220 ms, the positive predictive value for PM implantation was 16.5%, while the positive predictive value for PM implantation was 16% for QRS duration > 120 ms. However, for PR duration > 220 ms plus QRS No pacemaker group (n = 147); pacemaker group (n = 38). AV: atrioventricular; BMI: body mass index; CI: confidence interval; CT: computed tomography; LBBB: left bundle branch block; LVEF: left ventricular ejection fraction; OR: odds ratio; RBBB: right bundle branch block; TAVI: transcatheter aortic valve implantation.
duration > 120 ms, the positive predictive value for PM implantation reached 80%. Ratio analysis of prosthesis/transthoracic echocardiography aortic diameter and prosthesis/CT aortic diameter revealed a higher rate of PM implantation for a threshold of 1.1 (P = 0.0161 and P = 0.0409, respectively).
Discussion
This study shows that the incidence of PM implantation after TAVI is high (20.5%), especially in patients receiving the Medtronic CoreValve device (35.5%). The incidence of conduction disorders leading to permanent PM implantation appears to be related to initial PR interval duration, to the presence of pre-existing RBBB, to increased aortic annulus surface determined by CT scan and/or to increased aortic annulus size determined by echocardiography.
In our study, the incidence of PM implantation was around 20%. PM implantation rates appears to vary considerably in the literature. For example, in the FRANCE-TAVI registry [14] published in 2011, which included 244 patients, 35 of whom had a previously implanted PM, 29 patients received a PM after the procedure (29/209; 13.8%). In the PARTNER registry, which included 2559 patients, 586 of whom had a previously implanted PM, 173 received a new PM after the procedure (8.8% implantation rate) [6] . The low implantation rate in this last study can, however, be explained by the use of Edwards SAPIEN valves (diameters of 23 or 26 mm), which are known to induce fewer conduction disorders than the Medtronic CoreValve. For example, in a study including 243 patients without a previous PM, Khawaja et al. reported a 33.3% PM implantation rate in patients who received only the Medtronic CoreValve prosthesis [12] . In other studies, the rate of PM implantation appears to be similar or even higher than in our study. In a large German study published Incidence, indications and predicting factors of permanent pacemaker implantation after TAVI 7 in 2013, which included a total of 1347 patients who received either a Medtronic CoreValve or an Edwards SAPIEN device (1148 patients without previous PM implantation), the rate of PM implantation was 33.7% [29] . The high PM incidence after TAVI can be explained by the damage caused to the conduction tissue at various levels of the conduction system [7] [8] [9] . This deleterious effect appears to be greatest with the Medtronic CoreValve, which is autoexpandable and has a large stent size, thus explaining the high PM implantation rate [2, [30] [31] [32] .
Predicting factors for PM implantation include previous conduction disorders and anatomical features, such as aortic annulus diameter and/or device size. RBBB appears to be an obvious risk factor as the artificial valve may damage the left bundle branch, leading to complete AV block [33] . The presence of first-degree AV block as a predictor of PM has already been reported in previous studies [34] [35] [36] [37] [38] . It should, however, be emphasized that it is not only the existence of first-degree AV block that is a predicting factor for PM implantation, but also the value of the PR interval per se, even in the absence of a prolonged AV interval. To our knowledge, our results are the first to underline this notion; it must, however, must be confirmed by larger studies, as the reported OR was low (0.985), although highly significant (P = 0.0101). Furthermore, in patients with a preprocedural PR duration > 220 ms and a preprocedural QRS duration > 120 ms, the positive predictive value for PM implantation reached 80%. Such a high positive predictive value must be confirmed by larger studies and, if so, such values could be used as indices of ''prophylactic'' or periprocedural PM implantation.
In our study, a valve/aortic annulus diameter ratio > 1.1 was a predictive factor for PM implantation. This was probably because of an increase in the radial force applied to the interventricular wall and thus to the conductive tissue [39] .
The degree of aortic annulus calcification has also been described as a predictive factor for PM implantation. This can be explained by the direct involvement of the conductive tissue in the calcium flows and also by an increase in aortic annulus rigidity. This leads to an increase in tensions and forces applied at certain critical points in the septal annulus wall during TAVI [40] [41] [42] [43] . Calcification of the left ventricular outflow tract, especially the upper left ventricular outflow tract, located below the non-coronary cusp and extending from the annular region, is predictive of aortic root injury during TAVI [41] . In our study, there was a tendency for a higher PM implantation rate with an increased degree of aortic annulus calcification, although this did not reach statistical significance (P = 0.0512), probably because of a lack of statistical power.
An annulus with a large diameter measured by echocardiography appears to be a predictive factor of PM (OR: 1.2; P = 0.0447). This was reported previously by Ledwoch et al. [29, 44] , with a preprocedural aortic diameter of 23.69 mm in patients receiving PMs compared with 23.03 mm in patients without post-TAVI PM implantation (P <0.001). Indeed, large diameter valves required for large annuluses may cause greater conduction damage. It seems that even a small oversizing can induce a greater proportional increase in forces applied to the annulus, explaining why large valves and a large aortic annulus are independent risk factors for PM implantation. This is emphasized by the excess risk with the prosthetic valve diameters of 29 mm and above encountered in our study (P = 0.0014). Today, a low coronary insertion is a contraindication for TAVI implantation and, in our study, no patient with a coronary insertion within 10 mm of the aortic annulus underwent TAVI. On the other hand, in our study, a higher right coronary insertion was related to a higher incidence of PM implantation (15.8 vs 14.2 mm; P = 0.0254), but this must be interpreted cautiously as the right coronary insertion was higher in patients who received the Medtronic CoreValve (14.71 mm) compared with in those who received the Edwards SAPIEN device (14.29 mm; P = 0.43).
In our study, the transfemoral approach was a risk factor for PM implantation compared with the transapical approach [45] . This may be related to the absence of predilatation with the transapical approach. Indeed, aortic annulus balloon predilatation is known to increase damage to the conductive tissue [46] .
Study limitations
This was a single-centre non-prospective study with nonconsecutive patients because of missing preTAVI data. The number of included patients was relatively low (n = 185). We did not study long-term PM dependency.
Conclusions
Our study confirms that, after TAVI, the rate of PM implantation is high. Use of the Medtronic CoreValve, RBBB and first-degree AV block are major risk factors for post-TAVI PM implantation. A large aortic annulus with a threshold of 24.1 mm, a prosthetic/aortic annulus diameter ratio > 1.1 and valvular prostheses > 29 mm are independent risk factors for PM implantation. The combination of preTAVI prolonged PR interval and increased QRS duration could be used as a marker for periprocedural or even prophylactic PM implantation.
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